A recurrent mutation in the 5′‐UTR of <i>IFITM5</i> causes osteogenesis imperfecta type VMasaki Takagi, Tomonobu Hasegawa, Shuhei Sato et al.|American Journal of Medical Genetics Part A|2013Cited by 20
P1.07.49 Limited Impact of Adjuvant Chemotherapy in Alk-Positive Stage II-III Adenocarcinoma: A Multicenter CReGYT-03 ALK StudyAkira Hamada, Y. Tsutani, Shinya Katsumata et al.|Journal of Thoracic Oncology|2025Cited by 0